About PSM
Policy Resolution on Counterfeit Device Destruction, May 8, 2020
The following policy resolution was passed unanimously at the May 8, 2020 Advisory Board meeting: The Partnership for Safe Medicines believes that counterfeit medical devices are dangerous to American patients and that the U.S. Food and Drug Administration (FDA) should have the unequivocal power to seize and destroy these dangerous products whether they are found…
[...]How Many Tests Need to Be Performed to Know That a Batch of Pills is Safe?
Testing medicine for legitimacy is a complicated process. Across 24 different prescription medicines, the average cost to test a single dose is $2,750. However, ensuring that a batch of 100 pills is 90% certain to be safe requires testing at least 22 pills. Achieving 99.999% certainty requires even more testing, at tremendous expense. To learn more about this topic, read PSM’s summary: safedr.ug/Acri-Explained.
[...]Avoid COVID scams by buying medicine safely – Read our tips in English and en Español
Download our guide, AVOID SCAMS & COUNTERFEITS: Quick Tips to Safely Purchase Medicines Online (in English | en Español) to learn more about how to protect yourself and your loved ones from fake COVID-19 treatments.
[...]HHS comments come in overwhelmingly against Canadian drug importation proposal
Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.
[...]Former FDA Associate Commissioner Warns of the “Massive Safety Risks of Importation”
Source: Twitter This editorial by Peter J. Pitts was published in The Times Weekly on March 3, 2020. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner. Keep Canadian drugs out of U.S. medicine cabinets The Trump administration recently proposed two rules that would allow…
[...]Canadian Importation Does Not Work
The number of U.S. residents in states that are considering importing drugs from Canada is almost four times Canada’s own population. Canadian drug importation is not the structural solution we need.
[...]“5 Ways” consumer bookmark
Download our “5 Ways” Consumer Bookmark for a quick reference about how to protect yourself from counterfeit medicine.
[...]Policy Resolution, January 8, 2020
The following policy resolution was passed unanimously at the Jan. 8, 2020 board meeting in Washington DC. The governing board of the Partnership for Safe Medicines votes today to reiterate that the Partnership is organized to focus entirely of the safety of medicine as it travels through the supply chain, as we have since our…
[...]Infographic: Counterfeiting By The Numbers
Our infographic, “Counterfeiting by the Numbers,” highlights facts from the U.S. Department of Homeland Security’s January 2020 report, Combating Trafficking in Counterfeit and Pirated Goods, which documents the extraordinary scale of the global counterfeiting market and its effects across all economic sectors—including medicines.
[...]PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.
The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…
[...]